esp | eng

mail España / USA

+34 933 946 400 / +1 786-528-5273



Innovation is the basis of SALVAT business strategy.The company firmly believes that its success is closely linked to positive results from the products emerging from its R&D projects.

SALVAT believes that out-licensing is the foundation for internationalisation and SALVAT is focusing its efforts on seeking the best partner for each project, product and region.

SALVAT sees in-licensing as an opportunity to supplement  the product portfolio and make the most of the marketing expertise in the regions where SALVAT operates and in its therapeutic fields: gastroenterology, urology, ear nose and throat, ophthalmology and consumer health.


Project sharing: our choice

SALVAT sees collaboration being of key importance for growing together with our partners.

It is the way to guarantee the company’s future and competitiveness; it justifies the hard work of our R&D team and converts their efforts into marketing realities.


Success sharing: our commitment.

Our long history of alliances, including licensing, co-development and contract manufacturing agreements, shows how SALVAT aims to foster long-term business relationships based on agreements that are beneficial for both parties.

The result of this strategy is clear in our long list of satisfied Spanish and international partners, and a sales volume derived from technology transfer that represents more than 40% of the company’s total sales.


Laboratorios SALVAT S.A.
C\ Gall, 30-36 08950 - Esplugues de Llobregat - Barcelona España Tel. +34 933 946 400 Fax. +34 934 732 292
1200 Brickell Avenue, Suite 1950, Miami, FL 33131 (US) Tel. +1 786-528-5273